罗格列酮及其对药物警戒的意义。
Rosiglitazone and implications for pharmacovigilance.
作者信息
Kazi Dhruv
出版信息
BMJ. 2007 Jun 16;334(7606):1233-4. doi: 10.1136/bmj.39245.502546.BE.
Abstract
Postsurveillance data should be systematically collected, timely, and publicly available
摘要
监测后的数据应系统地收集，及时且公开可用。
相似文献
1
Rosiglitazone and implications for pharmacovigilance.罗格列酮及其对药物警戒的意义。
BMJ. 2007 Jun 16;334(7606):1233-4. doi: 10.1136/bmj.39245.502546.BE.
2
The rosiglitazone story--lessons from an FDA Advisory Committee meeting.罗格列酮事件——美国食品药品监督管理局咨询委员会会议的教训
N Engl J Med. 2007 Aug 30;357(9):844-6. doi: 10.1056/NEJMp078167. Epub 2007 Aug 8.
3
Rosiglitazone, marketing, and medical science.罗格列酮、市场营销与医学科学。
BMJ. 2010 Apr 7;340:c1848. doi: 10.1136/bmj.c1848.
4
Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.文迪雅事件的教训：治疗2型糖尿病药物研发的新范式
Diabetes Care. 2007 Dec;30(12):3141-4. doi: 10.2337/dc07-1908.
5
Revisiting the rosiglitazone story--lessons learned.重温罗格列酮事件——汲取的教训。
N Engl J Med. 2010 Aug 26;363(9):803-6. doi: 10.1056/NEJMp1008233. Epub 2010 Jul 21.
6
Rosiglitazone: failure of oversight or demons imagined?罗格列酮：监管不力还是凭空臆想？
J Fam Pract. 2007 Sep;56(9):696, 703.
7
Rosiglitazone: what went wrong?罗格列酮：问题出在哪里？
BMJ. 2010 Sep 6;341:c4848. doi: 10.1136/bmj.c4848.
8
The long Avandia endgame.文迪雅漫长的终局。
Lancet. 2011 Jul 9;378(9786):113. doi: 10.1016/s0140-6736(11)61071-4.
9
The record on rosiglitazone and the risk of myocardial infarction.罗格列酮与心肌梗死风险的记录。
N Engl J Med. 2007 Jul 5;357(1):67-9. doi: 10.1056/NEJMe078116. Epub 2007 Jun 5.
10
FDA committee urges tight restrictions on rosiglitazone.美国食品药品监督管理局委员会敦促对罗格列酮进行严格限制。
BMJ. 2010 Jul 16;341:c3862. doi: 10.1136/bmj.c3862.
引用本文的文献
1
Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.台湾地区噻唑烷二酮类药物安全警示及风险管理计划的效果
Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1026-35. doi: 10.1002/pds.3834. Epub 2015 Aug 6.
2
How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?美国食品药品监督管理局（FDA）的多项行动如何影响噻唑烷二酮类药物在美国医疗补助计划中的使用情况及报销费用？
Clin Ther. 2015 Jul 1;37(7):1420-1432.e1. doi: 10.1016/j.clinthera.2015.04.006. Epub 2015 May 11.
3
Use of the self-controlled case series method in drug safety assessment.自我对照病例系列法在药物安全性评估中的应用。
Expert Opin Drug Saf. 2011 May;10(3):337-40. doi: 10.1517/14740338.2011.562187. Epub 2011 Mar 15.
4
Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions.雷奈酸锶上市后安全性评估；一种用于早期发现药物不良反应的新型病例对照研究方法。
Br J Clin Pharmacol. 2008 Nov;66(5):689-94. doi: 10.1111/j.1365-2125.2008.03273.x. Epub 2008 Jul 31.
5
Pharmacovigilance in developing countries.发展中国家的药物警戒
BMJ. 2007 Sep 8;335(7618):462. doi: 10.1136/bmj.39323.586123.BE.
本文引用的文献
1
The record on rosiglitazone and the risk of myocardial infarction.罗格列酮与心肌梗死风险的记录。
N Engl J Med. 2007 Jul 5;357(1):67-9. doi: 10.1056/NEJMe078116. Epub 2007 Jun 5.
2
Rosiglitazone and cardiotoxicity--weighing the evidence.罗格列酮与心脏毒性——权衡证据
N Engl J Med. 2007 Jul 5;357(1):64-6. doi: 10.1056/NEJMe078117. Epub 2007 Jun 5.
3
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.罗格列酮心血管结局评估——一项中期分析。
N Engl J Med. 2007 Jul 5;357(1):28-38. doi: 10.1056/NEJMoa073394. Epub 2007 Jun 5.
4
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.罗格列酮对心肌梗死风险及心血管原因所致死亡的影响。
N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21.
5
Protecting the health of the public--Institute of Medicine recommendations on drug safety.保护公众健康——医学研究所关于药物安全的建议
N Engl J Med. 2006 Oct 26;355(17):1753-5. doi: 10.1056/NEJMp068228. Epub 2006 Oct 9.
6
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.muraglitazar对2型糖尿病患者死亡及主要不良心血管事件的影响。
JAMA. 2005 Nov 23;294(20):2581-6. doi: 10.1001/jama.294.20.joc50147. Epub 2005 Oct 20.
7
Lessons from the glitazones: a story of drug development.格列酮类药物的经验教训：一个药物研发的故事。
Lancet. 2001 Jun 9;357(9271):1870-5. doi: 10.1016/S0140-6736(00)04960-6.
8
Meta-analysis and its problems.荟萃分析及其问题。
BMJ. 1994 Sep 24;309(6957):789-92. doi: 10.1136/bmj.309.6957.789.
Zotero 插件